If you made any changes in Pure these will be visible here soon.

Research Output

Article

5-Fluorouracil modulated by leucovorin, methotrexate and mitomycin: Highly effective, low-cost chemotherapy for advanced colorectal cancer

Sobrero, A., Guglielmi, A., Cirillo, M., Recaldin, E., Frassineti, G. L., Aschele, C., Ravaioli, A., Testore, P., Caroti, C., Gallo, L., Pessi, M. A., Cortesi, E., Turci, D., Grossi, F. & Lablanca, R., Apr 20 2001, In : British Journal of Cancer. 84, 8, p. 1023-1028 6 p.

Research output: Contribution to journalArticle

5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer

Bolli, E., Saccomanno, S., Mondini, G., Aschele, C., Guglielmi, A., Ligas, B., Connio, M., Mori, A., Rosso, R., Sobrero, A., Tixi, L. & Pugliese, V., Jul 1995, In : Cancer Chemotherapy and Pharmacology. 35, 4, p. 339-342 4 p.

Research output: Contribution to journalArticle

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

Cascinu, S., Berardi, R., Salvagni, S., Beretta, G. D., Catalano, V., Pucci, F., Sobrero, A., Tagliaferri, P., Labianca, R., Scartozzi, M., Crocicchio, F., Mari, E. & Ardizzoni, A., Jan 15 2008, In : British Journal of Cancer. 98, 1, p. 71-76 6 p.

Research output: Contribution to journalArticle

Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in mice

Sobrero, A., Muzzulini, C., D'Amore, F., Bogliolo, G., Massa, G., Ghio, R. & Pannacciulli, I., 1982, In : Cancer Treatment Reports. 66, 12, p. 2061-2070 10 p.

Research output: Contribution to journalArticle

Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil

Mori, A., Bertoglio, S., Guglielmi, A., Aschele, C., Bolli, E., Tixi, L., Rosso, R. & Sobrero, A., Mar 1993, In : Cancer Chemotherapy and Pharmacology. 33, 2, p. 179-180 2 p.

Research output: Contribution to journalArticle

Adjuvant chemotherapy in the treatment of colon cancer: Randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)

Di Costanzo, F., Sobrero, A., Gasperoni, S., Dogliotti, L., Frassineti, L., Falcone, A., Lionetto, R., Bruzzi, P., Luppi, G., Gallo, L., Conte, P., Comandone, A., Turci, D., Marzola, M., Folco, U., Pfanner, E., Mestriner, M., Boni, C., Galli, C., Tonato, M. & 53 others, Rosso, R., Lavarello, A., Brema, F., Pastorino, G., Bottero, G., Fusco, V., Orsi, G., Cocchis, D., Guglielmi, A., Pronzato, P., Barsanti, G., Battistoni, M., Grezzi, P., Rinaldini, M., Taviani, R., Aglietta, M., Volta, C., Algeri, R., De Gennaro, P., Spinelli, I., Filidei, M., Arcabasso, G., Carli, A., Antonacci, R., Bumma, C., Berardo, R., Boglione, A., Di Napoli, A., Merlano, M., Grecchi, G., Porcile, G., Destefanis, M., Alabiso, O., Buosi, R., Botta, M., Castagneto, B., Zampaglione, V. M., Sozzi, P., Sidoti, V., Di Prima, S., Amadori, D., Nanni, O., Rosetti, P., Marangolo, M., Zumaglini, F., Tassinari, D., Pasquini, E., Artioli, F., Cesari, M., Gambi, A., Amaducci, L., Alessandrini, P. & Catalano, G., Sep 1 2003, In : Annals of Oncology. 14, 9, p. 1365-1372 8 p.

Research output: Contribution to journalArticle

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

Sobrero, A., Frassineti, G., Falcone, A., Dogliotti, L., Rosso, R., Costanzo, F. D. & Bruzzi, P., Jan 17 2005, In : British Journal of Cancer. 92, 1, p. 24-29 6 p.

Research output: Contribution to journalArticle

Adjuvant therapy for colon cancer: 12 months, 9 months, 6 months ... why not 3 months?

Sobrero, A. & Sciallero, S., Apr 2005, In : Annals of Oncology. 16, 4, p. 521-522 2 p.

Research output: Contribution to journalArticle

Adjuvant treatment of colorectal cancer in the elderly

Aschele, C., Guglielmi, A., Tixi, L. M., Bolli, E., Mori, A. M., Lionetto, R., Rosso, R. & Sobrero, A., 1995, In : Cancer Control. 2, 2 SUPPL., p. 36-38 3 p.

Research output: Contribution to journalArticle

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y. J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., Sep 1 2019, In : Clinical Colorectal Cancer. 18, 3, p. 183-191.e3

Research output: Contribution to journalArticle

Open Access

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y-J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., 2019, In : Clinical Colorectal Cancer. 18, 3, p. 183

Research output: Contribution to journalArticle

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP): Clinical Colorectal Cancer

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y-J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., 2019, In : Clin Colorectal Cancer. 18, 3, p. 183

Research output: Contribution to journalArticle

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study

Pastorino, A., Di Bartolomeo, M., Maiello, E., Iaffaioli, V., Ciuffreda, L., Fasola, G., Di Costanzo, F., Frassineti, G. L., Marchetti, P., Antoniotti, C., Leone, F., Zaniboni, A., Aprile, G., Zilocchi, C., Sobrero, A. & Bordonaro, R., Sep 1 2018, In : Clinical Colorectal Cancer. 17, 3, p. e457-e470

Research output: Contribution to journalArticle

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study

Pastorino, A., Di Bartolomeo, M., Maiello, E., Iaffaioli, V., Ciuffreda, L., Fasola, G., Di Costanzo, F., Frassineti, G. L., Marchetti, P., Antoniotti, C., Leone, F., Zaniboni, A., Aprile, G., Zilocchi, C., Sobrero, A. & Bordonaro, R., 2018, In : Clinical Colorectal Cancer. 17, 3, p. e457-e470

Research output: Contribution to journalArticle

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study

Pastorino, A., Di Bartolomeo, M., Maiello, E., Iaffaioli, V., Ciuffreda, L., Fasola, G., Di Costanzo, F., Frassineti, G. L., Marchetti, P., Antoniotti, C., Leone, F., Zaniboni, A., Aprile, G., Zilocchi, C., Sobrero, A. & Bordonaro, R., 2018, In : Clinical Colorectal Cancer. 17, 3, p. e457-e470

Research output: Contribution to journalArticle

Alternating bolus and continuous infusion 5-fluorouracil: A strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients

Guglielmi, A., Aschele, C., Grossi, F., Tixi, L. & Sobrero, A., 1996, In : Cytotechnology. 19, 3, p. 215-219 5 p.

Research output: Contribution to journalArticle

A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer

Fenoglio, D., Traverso, P., Parodi, A., Tomasello, L., Negrini, S., Kalli, F., Battaglia, F., Ferrera, F., Sciallero, S., Murdaca, G., Setti, M., Sobrero, A., Boccardo, F., Cittadini, G., Puppo, F., Criscuolo, D., Carmignani, G., Indiveri, F. & Filaci, G., Jun 2013, In : Cancer Immunology, Immunotherapy. 62, 6, p. 1041-1052 12 p.

Research output: Contribution to journalArticle

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: A retrospective, exploratory analysis of the CORRECT trial

Tabernero, J., Lenz, H. J., Siena, S., Sobrero, A., Falcone, A., Ychou, M., Humblet, Y., Bouché, O., Mineur, L., Barone, C., Adenis, A., Yoshino, T., Goldberg, R. M., Sargent, D. J., Wagner, A., Laurent, D., Teufel, M., Jeffers, M., Grothey, A. & Van Cutsem, E., Aug 1 2015, In : The Lancet Oncology. 16, 8, p. 937-948 12 p.

Research output: Contribution to journalArticle

Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

Peeters, M., Oliner, K. S., Price, T. J., Cervantes, A., Sobrero, A. F., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C. J. A., Strickland, A. H., Wilson, G., Ciuleanu, T. E., Roman, L., Van Cutsem, E., He, P., Yu, H., Koukakis, R., Terwey, J. H. & 3 others, Jung, A. S., Sidhu, R. & Patterson, S. D., Dec 15 2015, In : Clinical Cancer Research. 21, 24, p. 5469-5479 11 p.

Research output: Contribution to journalArticle

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group

Bleiberg, H., Decoster, G., de Gramont, A., Rougier, P., Sobrero, A., Benson, A., Chibaudel, B., Douillard, J. Y., Eng, C., Fuchs, C., Fujii, M., Labianca, R., Larsen, A. K., Mitchell, E., Schmoll, H. J., Sprumont, D. & Zalcberg, J., May 1 2017, In : Annals of Oncology. 28, 5, p. 922-930 9 p.

Research output: Contribution to journalArticle

A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients

Van Cutsem, E., Prenen, H., D'Haens, G., Bennouna, J., Carrato, A., Ducreux, M., Bouché, O., Sobrero, A., Latini, L., Staines, H., Oum'Hamed, Z., Dressler, H., Studeny, M. & Capdevila, J., Oct 1 2015, In : Annals of Oncology. 26, 10, p. 2085-2091 7 p., mdv286.

Research output: Contribution to journalArticle

A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients.

Nobile, M. T., Canobbio, L., Sobrero, A., Galligioni, E., Vidili, M. G., Fassio, T., Lo Re, G., Rubagotti, A., Sertoli, M. R. & Rosso, R., 1988, In : Advances in Experimental Medicine and Biology. 244, p. 213-218 6 p.

Research output: Contribution to journalArticle

Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial

Petrelli, F., Labianca, R., Zaniboni, A., Lonardi, S., Galli, F., Rulli, E., Rosati, G., Corallo, S., Ronzoni, M., Cardellino, G. G., Mattioli, R., Mambrini, A., Ciuffreda, L., Banzi, M., Pusceddu, V., Maiello, E., Zampino, M., Zagonel, V., Marchetti, P., Corsi, D. & 3 others, Rimassa, L., Cinieri, S. & Sobrero, A., Apr 2020, In : JAMA oncology. 6, 4, p. 547-551 5 p.

Research output: Contribution to journalArticle

Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy

Peeters, M., Siena, S., Van Cutsem, E., Sobrero, A., Hendlisz, A., Cascinu, S., Kalofonos, H., Devercelli, G., Wolf, M. & Amado, R. G., Apr 1 2009, In : Cancer. 115, 7, p. 1544-1554 11 p.

Research output: Contribution to journalArticle

Association of proton Pump inhibitors and capecitabine efficacy in advanced gastroesophageal cancer secondary analysis of the TRIO-013/LOGiC randomized clinical trial

Chu, M. P., Hecht, J. R., Slamon, D., Wainberg, Z. A., Bang, Y. J., Hoff, P. M., Sobrero, A., Qin, S., Afenjar, K., Houe, V., King, K., Koski, S., Mulder, K., Hiller, J. P., Scarfe, A., Spratlin, J., Huang, Y. J., Khan-Wasti, S., Chua, N. & Sawyer, M. B., Jun 1 2017, In : JAMA oncology. 3, 6, p. 767-773 7 p.

Research output: Contribution to journalArticle

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Cherny, N. I., Sullivan, R., Dafni, U., Kerst, J. M., Sobrero, A., Zielinski, C., de Vries, E. G. E. & Piccart, M. J., 2015, In : Annals of Oncology. 26, 8, p. 1547-1573 27 p.

Research output: Contribution to journalArticle

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Eng, C., Kim, T. W., Bendell, J., Argilés, G., Tebbutt, N. C., Di Bartolomeo, M., Falcone, A., Fakih, M., Kozloff, M., Segal, N. H., Sobrero, A., Yan, Y., Chang, I., Uyei, A., Roberts, L., Ciardiello, F., Ahn, J. B., Asselah, J., Badarinath, S., Baijal, S. & 30 others, Begbie, S., Berry, S., Canon, J. L., Carbone, R. G., Cervantes, A., Cha, Y. J., Chang, K., Chaudhry, A., Chmielowska, E., Cho, S. H., Chu, D., Couture, F., Cultrera, J., Cunningham, D., Van Cutsem, E., Cuyle, P. J., Davies, J., Dowden, S., Dvorkin, M., Ganju, V., Garcia, R. V., Kerr, R., Kim, T. Y., King, K., Kortmansky, J., Lam, K. O., Lee, J., Lee, A. S., Lesperance, B. & Maiello, E., 2019, In : The Lancet Oncology. 20, 6, p. 849-861 13 p.

Research output: Contribution to journalArticle

Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: A randomized phase II study

Bendell, J. C., Tournigand, C., Swieboda-Sadlej, A., Barone, C., Wainberg, Z. A., Kim, J. G., Pericay, C., Pastorelli, D., Tarazi, J., Rosbrook, B., Bloom, J., Ricart, A. D., Kim, S. & Sobrero, A. F., 2013, In : Clinical Colorectal Cancer. 12, 4, p. 239-247 9 p.

Research output: Contribution to journalArticle

Bevacizumab plus fluorouracil: The value of being part of a developing story

Sobrero, A. & Bruzzi, P., 2005, In : Journal of Clinical Oncology. 23, 16, p. 3660-3662 3 p.

Research output: Contribution to journalArticle

Biochemical determinants of the antineoplastic activity of fluorinated pyrimidines

Sobrero, A., Russello, O., Aschele, C., Bruzzo, C., Maioli, D., Gamba, E., Romanini, A., Nicolin, A. & Rosso, R., 1989, In : Italian Journal of Biochemistry. 38, 2, p. 152-154 3 p.

Research output: Contribution to journalArticle

Open Access

Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study.

Twelves, C. J., Butts, C. A., Cassidy, J., Conroy, T., Braud, F. D., Diaz-Rubio, E., Tabernero, J. M., Schoffski, P., Figer, A., Brunet, R., Grossmann, J., Sobrero, A. F. & Van Cutsem, E. J., Jul 2005, In : Clinical Colorectal Cancer. 5, 2, p. 101-107 7 p.

Research output: Contribution to journalArticle

Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer: Economic evaluation in an Italian NHS setting

Di Costanzo, F., Ravasio, R., Sobrero, A., Bertetto, O., Vinante, O., Luppi, G., Labianca, R., Amadori, D., Barone, C., Merlano, M. C., Longo, F., Mansueto, G., Antonuzzo, L. & Gasperoni, S., 2008, In : Clinical Drug Investigation. 28, 10, p. 645-655 11 p.

Research output: Contribution to journalArticle

Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: A double-blind, randomized phase III study (HORIZON III)

Schmoll, H. J., Cunningham, D., Sobrero, A., Karapetis, C. S., Rougier, P., Koski, S. L., Kocakova, I., Bondarenko, I., Bodoky, G., Mainwaring, P., Salazar, R., Barker, P., Mookerjee, B., Robertson, J. & Van Cutsem, E., Oct 10 2012, In : Journal of Clinical Oncology. 30, 29, p. 3588-3595 8 p.

Research output: Contribution to journalArticle

CELLULE STAMINALI EMOPOIETICHE MURINE DOPO SOMMINISTRAZIONE ACU TA E CRONICA DI VINCRISTINA

Translated title of the contribution: Hemopoietic ste cells in mice after acute and chronic administration of vincristineMassa, G., Bogliolo, G., Lanfranco, E., Sobrero, A. & Pannacciulli, I., 1979, In : Bollettino della Societa Italiana di Biologia Sperimentale. 55, 11, p. 1099-1103 5 p.

Research output: Contribution to journalArticle

Chemotherapy: Which drug and when?

Sobrero, A. & Bennicelli, E., Oct 2010, In : Annals of Oncology. 21, SUPPL. 7

Research output: Contribution to journalArticle

Clinical aspects of drug resistance.

Sobrero, A. & Bertino, J. R., 1986, In : Cancer Surveys. 5, 1, p. 93-107 15 p.

Research output: Contribution to journalArticle

Clinical calculator for Early mortality in Metastatic colorectal cancer: An analysis of Patients from 28 clinical trials in the aide et recherche en cancérologie digestive database

Renfro, L. A., Goldberg, R. M., Grothey, A., Sobrero, A., Adams, R., Seymour, M. T., Heinemann, V., Schmoll, H. J., Douillard, J. Y., Hurwitz, H., Fuchs, C. S., Diaz-Rubio, E., Porschen, R., Tournigand, C., Chibaudel, B., Hoff, P. M., Kabbinavar, F. F., Falcone, A., Tebbutt, N. C., Punt, C. J. A. & 7 others, Hecht, J. R., Souglakos, J., Bokemeyer, C., Cutsem, E. V., Saltz, L., Gramont, A. D. & Sargent, D. J., Jun 10 2017, In : Journal of Clinical Oncology. 35, 17, p. 1929-1937 9 p.

Research output: Contribution to journalArticle

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: Recommendations from an expert panel

Nordlinger, B., Van Cutsem, E., Gruenberger, T., Glimelius, B., Poston, G., Rougie, P., Sobrero, A. & Ychou, M., 2009, In : Annals of Oncology. 20, 6, p. 985-992 8 p.

Research output: Contribution to journalArticle

Comparison of in vitro drug sensitivity by inhibition of tritium release from [5-3H]-2'-deoxyuridine and a clonogenic assay

Aschele, C., Romanini, A., Nicolin, A., Rosso, R. & Sobrero, A., 1990, In : Anticancer Research. 10, 3, p. 759-764 6 p.

Research output: Contribution to journalArticle

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Goey, K. K. H., Sørbye, H., Glimelius, B., Adams, R. A., André, T., Arnold, D., Berlin, J. D., Bodoky, G., de Gramont, A., Díaz-Rubio, E., Eng, C., Falcone, A., Grothey, A., Heinemann, V., Hochster, H. S., Kaplan, R. S., Kopetz, S., Labianca, R., Lieu, C. H., Meropol, N. J. & 12 others, Price, T. J., Schilsky, R. L., Schmoll, H. J., Shacham-Shmueli, E., Shi, Q., Sobrero, A. F., Souglakos, J., Van Cutsem, E., Zalcberg, J., van Oijen, M. G. H., Punt, C. J. A. & Koopman, M., Sep 1 2018, In : European Journal of Cancer. 100, p. 35-45 11 p.

Research output: Contribution to journalArticle

Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly

Cartenì, G., Giannetta, L., Ucci, G., De Signoribus, G., Vecchione, A., Pinotti, G., Puglisi, F., Contillo, A., Pezzella, G., Orecchia, S., Beccaglia, P., Adamo, V., Aglietta, M., Alabiso, O., Altavilla, G., Amadori, D., Amunni, G., Bajetta, E., Bobbio Pallavicini, E., Bonsignori, M. & 54 others, Bordonaro, R., Bottini, A., Catalano, G., Chiavacci, A., Cigolari, S., Ciotti, R., Conte, P., Ricci, S., Contillo, A., Contu, A., Cortesi, E., Crispino, S., D'Aprile, M., De Chiara, A., De Signoribus, G., Del Prete, S., Donghi, M., Antonelli, P., Falcone, A., Fioretto, L., Fornasiero, A., Gamucci, T., Ghezzi, P., Giusto, M., Iacono, C., Lombardo, M., Manente, P., Mantovani, G., Marchetti, P., Masina, A., Mattioli, R., Menichetti, E., Minisini, A., Neri, B., Nettuno, R., Palazzo, S., Palmeri, S., Palmiotti, G., Patrone, F., Pezzella, G., Pinotti, G., Pizza, C., Pollera, F., Savarese, A., Savarino, A., Sbalzarini, G., Serravezza, G., Siena, S., Sobrero, A., Surace, G., Vecchione, A., Vietti Ramus, G., Vinante, O. & Zagonel, V., Sep 2007, In : Supportive Care in Cancer. 15, 9, p. 1057-1066 10 p.

Research output: Contribution to journalArticle

Current challenges and future perspectives in the medical treatment of solid tumours

Sobrero, A. & Di Benedetto, M., Oct 2008, In : European Journal of Cancer, Supplement. 6, 14, p. 91-93 3 p.

Research output: Contribution to journalArticle

Current controversies in the adjuvant therapy of colon cancer

Sobrero, A. & Guglielmi, A., 2004, In : Annals of Oncology. 15, SUPPL. 4

Research output: Contribution to journalArticle

Current issues in adjuvant treatment of stage II colon cancer

André, T., Sargent, D., Tabernero, J., O'Connell, M., Buyse, M., Sobrero, A., Misset, J. L., Boni, C. & De Gramont, A., Jun 2006, In : Annals of Surgical Oncology. 13, 6, p. 887-898 12 p.

Research output: Contribution to journalArticle

Current opinion on optimal treatment choices in first-line therapy for advanced or metastatic colorectal cancer: Report from the adelaide colorectal tumour group meeting; Stockholm, Sweden; September 2008

Price, T. J., Tebbutt, N. C., Karapetis, C. S., Segelov, E., Pavlakis, N., Cunningham, D., Sobrero, A. F., Haller, D. G. & Shapiro, J. D., Jan 1 2010, In : Clinical Colorectal Cancer. 9, 1, p. 8-14 7 p.

Research output: Contribution to journalArticle

Current opinion on optimal treatment for colorectal cancer

Price, T. J., Segelov, E., Burge, M., Haller, D. G., Ackland, S. P., Tebbutt, N. C., Karapetis, C. S., Pavlakis, N., Sobrero, A. F., Cunningham, D. & Shapiro, J. D., May 2013, In : Expert Review of Anticancer Therapy. 13, 5, p. 597-611 15 p.

Research output: Contribution to journalArticle

Current strategies to reduce cisplatin toxicity

Sobrero, A., Guglielmi, A., Aschele, C. & Rosso, R., 1990, In : Journal of Chemotherapy. 2, 1, p. 3-7 5 p.

Research output: Contribution to journalArticle